1. Temozolomide Oncology Drug Advisory Committee March 13, 2003 Craig L. Tendler, M.D. Vice President, Oncology Clinical Research 2. Agenda Basis for the accelerated approval…

Slide 1Bevacizumab in MBC 1 Breast Cancer Take home message Sabino De Placido Slide 2 Survival of Patients with Metastatic Breast Cancer 1974 - 2000 Slide 3 International…

Slide 1Please note, these are the actual video-recorded proceedings from the live CME event and may include the use of trade names and other raw, unedited content. Select…

Slide 1New Strategies on Horizon Tony Mok MD Dept of Clinical Oncology The Chinse University of Hong Kong Slide 2 TKI is forever Addressing the difference Novel Target Slide…

Slide 1 G. Cartenì Direttore U.O.S.C. di Oncologia Medica A.O.R.N. A. Cardarelli Napoli Roma, 22 febbraio 2013 Highlights in the management of renal cell carcinoma Criteria…

1. Please see full prescribing information. SUTENT® (sunitinib malate) Slide Kit . 2. Please see full prescribing information. 2 Contents Slide Indications 3 Dosing 4 Mechanism…

1. Targeted therapy for Hodgkin’s Lymphoma Larry W. Kwak, M.D., Ph.D. Chairman, Department of Lymphoma/Myeloma Justin Distinguished Chair in Leukemia Research Co-Director,…

Background Journal Club Ranjita Pallavi Fellow 1 Department of Hematology/Oncology Westchester Medical Center Introduction Despite recent advances such as the anti-cytotoxic…

Slide 1GDC-0449 in Patients With Advanced Chondrosarcomas: a French Sarcoma Group / French and US NCI phase II collaborative study Antoine Italiano, Axel Le Cesne, Jean-Yves…

Slide 1 Validation of RANO Criteria: Contribution of T2/FLAIR Assessment in Patients with Recurrent Glioblastoma Treated with Bevacizumab Presented By Raymond Huang at 2014…